CheckMate 77T
CheckMate 77T: Phase III Trial of Neoadjuvant Nivolumab + Chemotherapy vs Placebo + Chemotherapy With Adjuvant Nivolumab or Placebo in Stage II-IIIB NSCLC

Released: October 26, 2023

Activity

Progress
1
Course Completed